Takahiro Oyama

Structure–activity relationships of the thujaplicins for inhibition of human tyrosinase

Atsushi Yoshimori, Takahiro Oyama, Satoshi Takahashi et al. · Bioorganic & Medicinal Chemistry · 2014 · 50 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Inhibitory Activity +9

Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors

Takahiro Oyama, Satoshi Takahashi, Atsushi Yoshimori et al. · Bioorganic & Medicinal Chemistry · 2016 · 37 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +8

Papaverine identified as an inhibitor of high mobility group box 1/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses

Kenya Tamada, Shingo Nakajima, Natsumi Ogawa et al. · Biochemical and Biophysical Research Communications · 2019 · 32 citations

Inflammation, Cytokine, Anti-inflammatory +12

The structural differences between mushroom and human tyrosinase cleared by investigating the inhibitory activities of stilbenes

Takahiro Oyama, Atsushi Yoshimori, Haruka Ogawa et al. · Journal of Molecular Structure · 2022 · 32 citations

Medicinal Chemistry, Structural Differences, Biochemistry +6

Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors

Sei-ichi Tanuma, Kiyotaka Katsuragi, Takahiro Oyama et al. · Molecules · 2020 · 15 citations · Full text